Reuters: Global Markets: Cytori's aesthetic surgery device gets FDA nod

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Cytori's aesthetic surgery device gets FDA nod Mar 16th 2012, 13:54 Fri Mar 16, 2012 9:54am EDT (Reuters) - Cytori Therapeutics (CYTX.O) said U.S. health regulators approved an upgraded version of its device used in fat reduction surgeries, sending the company's shares up as much as 21 percent on Friday morning. The device -- Puregraft 850 -- is already approved in Europe, and provides processing of up to 850 ml of tissue -- a much larger volume than the original system, according to the medical device maker. Puregraft is Cytori's key technology, used for the preparation of a fat graft to help in targeted fat reduction. The first system, Puregraft 250, was approved in the United States in 2010. Cytori's shares were trading up 19 percent at $3.36 on Friday, making them one of the biggest percentage gainers on the Nasdaq. They touched a high of $3.42 earlier in the session.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions